Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine

By Jianneng M.   Hine P.M.   Clough E.R.   Fish D.   Coughlin R.T.   Beltz G.A.   Shew M.G.  

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1366-1374

Elsevier

Access to resources Recommend Favorite

Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants

By Johansen K.   Schroder U.   Svensson L.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 368-375

Elsevier

Access to resources Recommend Favorite

Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs

By Fekadu M.   Nesby S.L.   Shaddock J.H.   Schumachert C.L.   Linhart S.B.   Sanderlin D.W.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 465-468

Elsevier

Access to resources Recommend Favorite

Some important issues in the planning of phase III HIV vaccine efficacy trials

By Boily M.-C.   Masse B.R.   Desai K.   Alary M.   Anderson R.M.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 989-1004

Elsevier

Access to resources Recommend Favorite

Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials

By Cornu C.   Yzebe D.   Leophonte P.   Gaillat J.   Boissel J.P.   Cucherat M.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4780-4790

Elsevier

Access to resources Recommend Favorite